Douglas John Barry
Compliance Officer chez TANGO THERAPEUTICS, INC.
Fortune : 377 357 $ au 30/06/2024
Profil
Douglas John Barry is currently the Director at Redwood Toxicology Laboratory, Inc. and the Secretary, Chief Legal & Compliance Officer at Tango Therapeutics, Inc. He previously worked as the Secretary & Director at Achillion Pharmaceuticals, Inc., Director at Alere Toxicology Services, Inc., Director at BBI Diagnostics Group 2 Plc from 2015 to 2017, Vice President-Corporate Law at Alexion Pharmaceuticals, Inc. from 2018 to 2020, and Associate General Counsel at Alere, Inc. from 2015 to 2018.
He holds a graduate degree from Northwestern University School of Law and Virginia International University of, and an undergraduate degree from Hobart & William Smith Colleges.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TANGO THERAPEUTICS, INC.
0,04% | 07/02/2024 | 43 981 ( 0,04% ) | 377 357 $ | 30/06/2024 |
Postes actifs de Douglas John Barry
| Sociétés | Poste | Début |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Compliance Officer | 01/08/2021 |
Redwood Toxicology Laboratory, Inc.
 Redwood Toxicology Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Redwood Toxicology Laboratory, Inc. provides drugs of abuse lab testing services. It also offers on-site screening devices for the correctional, rehabilitation and point-of-care markets. The firm provides drug testing solutions that allow clients to design drug testing programs, as well as combines lab services with on-site screening devices. The company was founded by Robert Mount in 1994 and is headquartered in Santa Rosa, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Douglas John Barry
| Sociétés | Poste | Fin |
|---|---|---|
| ALERE INC | Conseiller Juridique Général | 01/04/2018 |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Directeur/Membre du Conseil | 03/10/2017 |
| ACHILLION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
| ALEXION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Alere Toxicology Services, Inc.
 Alere Toxicology Services, Inc. Miscellaneous Commercial ServicesCommercial Services Alere Toxicology Services, Inc. provides employee drug testing services. It tests for such drugs as marijuana, cocaine, PCP, opiates, methamphetamines and barbiturates. The firm also tests for chemicals that may have been ingested in an effort to alter tests results. The company was founded in 1978 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Douglas John Barry
| Northwestern University School of Law | Graduate Degree |
| Virginia International University of | Graduate Degree |
| Hobart & William Smith Colleges | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
BBI Diagnostics Group 2 Plc
BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Health Services |
Alere Toxicology Services, Inc.
Alere Toxicology Services, Inc. Miscellaneous Commercial ServicesCommercial Services Alere Toxicology Services, Inc. provides employee drug testing services. It tests for such drugs as marijuana, cocaine, PCP, opiates, methamphetamines and barbiturates. The firm also tests for chemicals that may have been ingested in an effort to alter tests results. The company was founded in 1978 and is headquartered in New York, NY. | Commercial Services |
Redwood Toxicology Laboratory, Inc.
Redwood Toxicology Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Redwood Toxicology Laboratory, Inc. provides drugs of abuse lab testing services. It also offers on-site screening devices for the correctional, rehabilitation and point-of-care markets. The firm provides drug testing solutions that allow clients to design drug testing programs, as well as combines lab services with on-site screening devices. The company was founded by Robert Mount in 1994 and is headquartered in Santa Rosa, CA. | Commercial Services |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Alere, Inc.
 Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
